Sector valuations Arrowhead Pharmaceuticals, Inc.
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.88 USD | +7.64% |
|
+11.72% | +0.43% |
Main competitors
P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
98.5x | - | -0.95x | 2.69x | -216.46x | 58.22x | -.--% | 2.61B | ||
47.59x | 5.19x | -2.33x | 8.06x | 35.91x | 37.13x | -.--% | 33.32B | ||
17.08x | 2.99x | 0.68x | 4.19x | 11.45x | 13.41x | 1.7% | 27.79B | ||
-23.67x | 1.28x | -0.52x | 5.91x | -9.65x | -8.96x | -.--% | 27.52B | ||
-57.55x | - | -1.98x | - | -57.84x | -56.85x | -.--% | 18.37B | ||
-18.06x | 53.6x | 4.38x | 40.28x | -19.81x | -19.57x | -.--% | 18.32B | ||
24.56x | 2.04x | 1.04x | 4.3x | 12.49x | 15.98x | -.--% | 13.43B | ||
13.28x | 2.08x | -0.89x | 2.61x | 7.36x | 7.95x | -.--% | 13.23B | ||
1970.31x | 13.05x | -18.16x | 25.43x | 290.64x | 1273.32x | -.--% | 12.55B | ||
19.13x | 4.31x | 0.62x | 4.6x | 13.23x | 13.76x | -.--% | 12.02B | ||
-117x | 25.47x | -0.88x | 36.34x | -197.36x | -115.95x | -.--% | 10.18B | ||
252.46x | - | -2.12x | 22.29x | - | 234.22x | - | 9.55B | ||
-42.57x | 7.32x | 12.32x | 6.6x | -54.91x | -46.11x | -.--% | 7.27B | ||
-24.17x | 13.09x | 0.58x | 9.34x | -16.53x | -18.99x | -.--% | 6.85B | ||
29.76x | 5.41x | 0.31x | 9.88x | 30.96x | 33.5x | 0.44% | 5.95B | ||
-16.46x | 6.6x | -0.63x | - | -17.56x | -15.19x | -.--% | 5.85B | ||
23.4x | 6.01x | 0.94x | - | - | - | - | 5.82B | ||
57.89x | 1.94x | -2.44x | 3.52x | 15.99x | 29.22x | 0.31% | 5.81B | ||
-36.84x | 21.52x | 0.91x | 15.73x | -65.85x | -41.68x | -.--% | 4.94B | ||
Average | 116.72x | 10.74x | -0.48x | 12.61x | -14.00x | 77.41x | 0.14% | 12.71B | |
Weighted average by Cap. | 111.29x | 10.29x | -0.79x | 12.36x | 2.92x | 73.21x | 0.23% |
- Stock Market
- Equities
- ARWR Stock
- Sector Arrowhead Pharmaceuticals, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition